Kurt Hammond Named Exo® Chief Commercial Officer to Drive the Future of Medical Imaging
Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced the appointment of Kurt Hammond to Chief Commercial Officer.
- Exo (pronounced “echo”), a pioneering medical imaging software and devices company, today announced the appointment of Kurt Hammond to Chief Commercial Officer.
- Hammond most recently served as Chief Growth Officer at eMed Digital Healthcare, where he oversaw sales, customer success, product management, marketing and partnership development functions for a first-of-its-kind point-of-care diagnostic lab platform.
- After Merge Healthcare was acquired by IBM in 2015, Hammond was named VP of Global Imaging Sales for IBM Watson Health, eventually being promoted to Global VP of Partnerships and Business Development.
- “As Exo expands its medical imaging ecosystem, Kurt’s experience leading market-altering health tech companies will be core to our success.”
Hammond’s appointment as Chief Commercial Officer comes at a pivotal time in Exo’s trajectory in delivering simple and accessible medical imaging to all.